A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life

NCT03774875 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
277
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen